Profile: Sirtex Medical Limited specializes in the research, development and commercialization of effective treatments for liver cancer using novel small particle technology. SIR-Spheres microspheres are tiny resin microspheres that are loaded with yttrium-90, a radioisotope that emits pure beta radiation. Yttrium-90 has a half life of about 64 hours. The radiation from yttrium-90 is largely confined to a tissue depth of 2-3 mm. After injection into the artery supplying blood to the tumors, the spheres are trapped in the tumor's vascular bed, where they destroy the tumor cells by delivering the beta radiation. The radiation is targeted and contained within the patient's body & after 14 days the majority of the radiation effect has occurred. SIR-Spheres microspheres are considered a regional treatment as the radiation is directed to the liver and does not affect other organs in the body.
FDA Registration Number: 9710358
US Agent: Linda Teigland / Sirtex Medical Limited
Phone: +1-(847)-828-4491 Fax: +1-(978)-229-9585 E-Mail:
5 Products/Services (Click for related suppliers)
|
• Leaded Syringe Holder (FDA Code: IWR / 892.6500) A personnel protective shield is a device intended for medical purposes to protect the patient, the operator, or other persons from unnecessary exposure to radiation during radiologic procedures by providing an attenuating barrier to radiation. This generic type of device may include articles of clothing, furniture, and movable or stationary structures. |
• Leaded Vial Shield (FDA Code: IWW / 892.6500) |
• Manual Radionuclide Applicator (FDA Code: IWJ / 892.5650) A manual radionuclide applicator system is a manually operated device intended to apply a radionuclide source into the body or to the surface of the body for radiation therapy. This generic type of device may include patient and equipment supports, component parts, treatment planning computer programs, and accessories. |
• Microspheres Radionuclide (FDA Code: NAW) |
• Personnel Protective Shield (FDA Code: KPY / 892.6500) |